Quantel Medical, a France-based provider of technologies for the treatment of ocular diseases, has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its Vitra Multispot laser system.
The device, which features an intelligent design, combines advanced pattern scanning and solid-state green laser technologies in a compact portable platform.
Quantel Medical CEO Jean-Marc Gendre said the system allows ophthalmologists to treat patients with diabetic eye disease.
"Efficient and less-painful pattern-scanning delivery of laser to treat diabetic eye disease is no longer reserved for the elite treatment centers," Gendre added.
University Retina president and managing partner Rama Jager said, "The Vitra Multispot has accelerated our capability to manage the growing number of diabetic patients coming to our practice for care and improved our reputation for superior patient care since the pattern-scanning laser treatment with the Vitra Multispot is less painful compared to the previous treatments many patients received with a conventional laser."
